Indications
It is suitable for the control of hyperphosphatemia in adult patients with chronic kidney disease receiving dialysis treatment.
Dosage
For oral use, swallow the tablet whole; see instructions for details.
Active Pharmaceutical Ingredient (API)
Ferric Citrate 500mg, eq. to 105mg Ferric Iron
